Added to YB: 2024-02-21
Pitch date: 2024-02-21
VKTX:US [bullish]
Viking Therapeutics, Inc.
+5.34%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.
Market Cap
$4.4B
Pitch Price
$35.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
-13.51
P/E
-18.45
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Viking Therapeutics, Inc. VKTX:US
A summary for this pitch has not been created yet.
Read full article (0 min)